Literature DB >> 12480733

Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.

Gjumrakch Aliev1, Dilara Seyidova, Maxwell L Neal, Jiong Shi, Bruce T Lamb, Sandra L Siedlak, Harry V Vinters, Elizabeth Head, George Perry, Joseph C Lamanna, Robert P Friedland, Carl W Cotman.   

Abstract

We have studied the ultrastructural features of vascular lesions and mitochondria in brain vascular wall cells from human AD brain biopsy, human short postmortem brain tissues, and yeast artificial chromosome (YAC) and C57B6/SJL transgenic positive (Tg+) mice overexpressing amyloid beta precursor protein (AbetaPP). In situ hybridization using mitochondrial DNA (mtDNA) probes for human wild type, 5 kb deleted, and mouse mtDNA was performed, along with immunocytochemistry using antibodies against amyloid precursor protein (APP), 8-hydroxy-2'-guanosine (8-OHG), and cytochrome c oxidase (COX). There was a higher degree of amyloid deposition in the vascular walls of the human AD, YAC, and C57B6/SJL Tg (+) mice compared to age-matched controls. In addition, vessels with more severe lesions showed immunopositive staining for APP and possessed large, lipid-laden vacuoles in the cytoplasm of endothelial cells (EC). Significantly more mitochondrial abnormalities were seen in human AD, YAC, and C57B6/SJL Tg (+) mouse microvessels where lesions occurred. In situ hybridization using wild and chimera (5 kb) mtDNA probes revealed positive signals in damaged mitochondria from the vascular endothelium and in perivascular cells of lesioned microvessels close to regions of large amyloid deposition. These features were absent in undamaged regions of human AD tissues, YAC and C57B6/SJL Tg (+) mouse tissues, and in age-matched control subjects. In addition, vessels with atherosclerotic lesions revealed endothelium and perivascular cells possessing clusters of wild and deleted mtDNA positive probes. These mtDNA deletions were accompanied by increased amounts of immunoreactive APP, 8-OHG, and COX in the same cellular compartment. Our observations demonstrate that vascular wall cells, especially their mitochondria, appear to be a central target for oxidative stress-induced damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480733     DOI: 10.1111/j.1749-6632.2002.tb04798.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  25 in total

1.  The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.

Authors:  Mark E Obrenovich; Hector H Palacios; Eldar Gasimov; Jerzy Leszek; Gjumrakch Aliev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-03

Review 2.  Role of somatic mutations in vascular disease formation.

Authors:  Sarah M Weakley; Jun Jiang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; F Charles Brunicardi; Richard A Gibbs; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2010-03       Impact factor: 5.225

3.  Mitochondrial toxic effects of Aβ through mitofusins in the early pathogenesis of Alzheimer's disease.

Authors:  Zhaofei Wu; Yushan Zhu; Xingshui Cao; Shufeng Sun; Baolu Zhao
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

4.  Dietary supplementation with tBHQ, an Nrf2 stabilizer molecule, confers neuroprotection against apoptosis in amyloid β-injected rat.

Authors:  Fatemeh Nouhi; Solaleh Khoramian Tusi; Azadeh Abdi; Fariba Khodagholi
Journal:  Neurochem Res       Date:  2011-02-04       Impact factor: 3.996

Review 5.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

Review 6.  Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?

Authors:  O O Ogunshola; X Antoniou
Journal:  Cell Mol Life Sci       Date:  2009-09-11       Impact factor: 9.261

Review 7.  Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.

Authors:  Gjumrakch Aliev; Mark A Smith; Mark E Obrenovich; Jack C de la Torre; George Perry
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.

Authors:  Justin C Shenk; Jiankang Liu; Kathryn Fischbach; Kui Xu; Michel Puchowicz; Mark E Obrenovich; Eldar Gasimov; Ludis Morales Alvarez; Bruce N Ames; Joseph C Lamanna; Gjumrakch Aliev
Journal:  J Neurol Sci       Date:  2009-04-01       Impact factor: 3.181

9.  Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.

Authors:  Gjumrakch Aliev; Jiankang Liu; Justin C Shenk; Kathryn Fischbach; Gerardo J Pacheco; Shu G Chen; Mark E Obrenovich; Walter F Ward; Arlan G Richardson; Mark A Smith; Eldar Gasimov; George Perry; Bruce N Ames
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

Review 10.  Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.

Authors:  Mark E Obrenovich; Ludis A Morales; Celia J Cobb; Justin C Shenk; Gina M Méndez; Kathryn Fischbach; Mark A Smith; Eldar K Qasimov; George Perry; Gjumrakch Aliev
Journal:  J Cell Mol Med       Date:  2008-10-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.